CJC-1295 supports the activation of growth hormone-releasing pathways while Ipamorelin helps promote amplitude and frequency of hormone pulses through ghrelin-mediated signaling. Together they encourage coordinated peptide activity that may help support recovery and performance when used consistently. Their complementary mechanisms allow each to reinforce the other's potential effects on tissue repair, metabolism, and overall homeostasis. In injectable form, the peptides are delivered with controlled precision to support routine use as part of a broader wellness and performance strategy.

• Combines CJC-1295 and Ipamorelin for synergistic peptide support
• Supports pathways linked to recovery and metabolic function
• Designed for routine peptide protocol integration
• May support tissue resilience and training adaptation
• Clean formulation without unnecessary additives

Individuals incorporating peptide support into structured recovery, training, or wellness protocols who want a synergistic dual-peptide option that supports hormone signaling pathways and tissue maintenance.